Papillary muscle intervention vs mitral ring annuloplasty in ischemic mitral regurgitation by Micali, Linda R. et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
Papillary muscle intervention vs mitral ring
annuloplasty in ischemic mitral regurgitation
Journal Item
How to cite:
Micali, Linda R.; Qadrouh, Mohammad N.; Parise, Orlando; Parise, Gianmarco; Matteucci, Francesco; Jong,
Monique; Tetta, Cecilia; Moula, Amalia I.; Johnson, Daniel M. and Gelsomino, Sandro (2020). Papillary muscle
intervention vs mitral ring annuloplasty in ischemic mitral regurgitation. Journal of Cardiac Surgery (Early Access).
For guidance on citations see FAQs.
c© 2020 The Authors
Version: Version of Record
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.1111/jocs.14407
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
© 2020 The Authors. Journal of Cardiac Surgery published by Wiley Periodicals, Inc.
J Card Surg. 2020;1–9. wileyonlinelibrary.com/journal/jocs | 1
DOI: 10.1111/jocs.14407
R EV I EW ART I C L E
Papillary muscle intervention vs mitral ring annuloplasty
in ischemic mitral regurgitation
Linda R. Micali BSc | Mohammad N. Qadrouh | Orlando Parise MSc |
Gianmarco Parise | Francesco Matteucci MD | Monique de Jong | Cecilia Tetta MD |
Amalia I. Moula BSc | Daniel M. Johnson PhD | Sandro Gelsomino MD, PhD, FESC
Department of Cardiothoracic Surgery,
Maastricht University Hospital, Maastricht,
The Netherlands
Correspondence
Sandro Gelsomino, MD, PhD, FESC, Department
of Cardiothoracic Surgery, Cardiovascular
Research Institute Maastricht University,
Universiteitssingel 50, 6229 ER Maastricht,
The Netherlands.
Email: Sandro.gelsomino@maastrichtuniveristy.nl
Abstract
Background and Aims: The main pathophysiological factor of chronic ischemic mitral
regurgitation (MR) is the outward displacement of the papillary muscles (PMs) leading
to leaflet tethering. For this reason, papillary muscle intervention (PMI) in combination
with mitral ring annuloplasty (MRA) has recently been introduced into clinical practice
to correct this displacement, and to reduce the recurrence of regurgitation.
Methods: A meta‐analysis was conducted comparing the outcomes of PMI and MRA
performed in combination vs MRA performed alone, in terms of MR recurrence and
left ventricular reverse remodeling (LVRR). A meta‐regression was carried out to
investigate the impact of the type of PMI procedure on the outcomes.
Results: MR recurrence in patients undergoing both PMI and MRA was lower than in
those who only had MRA (log incidence rate ratio, −0.66; lower‐upper limits, −1.13 to
0.20; I2 = 0.0%; p = .44; Egger’s test: intercept 0.35 [−0.78 to 1.51]; p = .42).
The group with both PMI and MRA and that with only MRA showed a slightly higher
reduction in left ventricular diameters (−5.94%; −8.75% to 3.13%,). However, in both
groups, LVRR was <10%. No difference was detected between PM relocation/
repositioning and papillary muscle approximation in terms of LVRR (p = .33).
Conclusions: Using PMI and MRA together has a lower MR recurrence than using
MRA alone. No significant LVRR was observed between the two groups nor between
the PMI techniques employed.
K E YWORD S
ischemic mitral regurgitation, left ventricular remodeling, mitral annuloplasty, mitral
regurgitation recurrence, papillary muscle intervention
1 | INTRODUCTION
The pathophysiology of chronic ischemic mitral regurgitation (CIMR) is
complex and its treatment is challenging, burdened by a high rate of
mitral regurgitation (MR) recurrence secondary to continuous adverse
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left ventricular remodeling.1-4 The main pathophysiological factor of
CIMR is the outward displacement of papillary muscles (PM) leading to
leaflet tethering.5 Mitral ring annuloplasty (MRA) is the gold standard for
the treatment of this pathology6 but is followed by high MR recurrence.7
For this reason, papillary muscle interventions (PMIs) in
combination with MRA have recently been introduced into clinical
practice to correct the outward displacement of the PM, and to
reduce the recurrence of MR.8-11
Nonetheless, the long‐term implications of PMI added to MRA on
the efficacy of the repair remains uncertain and is still a matter of
intense discussion.
The aim of this meta‐analysis was to investigate the efficacy of
PMI +MRA compared with only MRA in terms of MR recurrence and
left ventricular reverse remodeling (LVRR). In addition, we tested
whether a specific PMI procedure is superior over another regarding
these outcomes.
2 | MATERIALS AND METHODS
2.1 | Search strategy
A literature search was conducted in conformity with the principles
of the Preferred Reporting Items for Systematic Review and Meta‐
Analyses (PRISMA).12 The search strategy was decided by two
authors (LRM and MNQ) and approved by another reviewer (MdJ).
Additional references identified through original articles were
reviewed manually and cross‐checked for other relevant reports.
Titles and abstracts of all articles published in the period between
January 2000 and July 2019 were initially screened.
The literature search was performed by one investigator and
focused on the identification of articles concerning PMI for
ischemic MR. The search engine selected for this review was
PubMed database. The search strategy included the following
search terms: “Mitral Insufficiency” and “Ischemia” and “Papillary
Muscle Intervention”; “Papillary Muscles/surgery”[Mesh]) and
“Mitral Valve Annuloplasty/methods”[Mesh]) and “Cardiac Surgical
Procedures”[Mesh]; “Papillary Muscle Intervention” and “Mitral
Annuloplasty”; “Papillary Muscles/surgery”[Mesh]) and “Mitral
Valve Annuloplasty”[Mesh].
2.2 | Selection process
Article selection was based on the following inclusion criteria:
(a) studies with cohorts of more than 10 patients, (b) studies
contemplating a follow‐up after at least 2 months from the
procedure, (c) studies reporting preoperative and follow‐up echo-
cardiographic evaluation, (d) papers reporting a clear comparison
between PMI +MRA and isolated MRA, and (e) studies concerning
direct PMI. The exclusion criteria were: (a) nonhuman studies, (b) case
reports, (c) previous reviews and/or meta‐analyses, (d) editorials,
(e) studies consisting of less than 10 individuals, (f) studies reporting
the presence of concomitant diseases, (g) studies reporting con-
comitant ventriculoplasty and/or chordal shortening procedures,
(h) articles failing in reporting detailed data about the etiology of
MR, (i) significant operative variabilities among the studies, and
(j) absence of data regarding the grade of MR.
2.3 | Quality assessment
The quality of included studies was assessed using a rating scale
based on the Downs and Black checklist for measuring.13 This rating
scale is aimed at assessing the quality of randomized and
nonrandomized studies in terms of reporting, external validity,
internal validity—bias—and power. Each component of the checklist
is rated using a binary score (0 or 1) except for two items which are
rated on a scale from 0 to 2 and from 0 to 5, respectively.13 We
employed a version of the checklist including 18 items.
Two independent researchers (LRM and GP) collected the ratings.
Any divergences were resolved by a third reviewer (OP) and
quantified using Cohen’s kappa.14
2.4 | Endpoints
The primary endpoints of this study were: (a) recurrence of MR,
defined as the presence of regurgitation of grade ≥2+ at the follow‐
up in patients with no or trivial MR at discharge15; (b) LVRR defined
as ≥10% reduction in left ventricle end‐diastolic diameter (LVEDD)
from its preoperative value.16
2.5 | Statistical analysis
Meta‐analysis was conducted using v.3.6.1 (R Foundation for
Statistical Computing, Vienna, Austria) and Comprehensive Meta‐
Analysis v.2.2 (Biostat, Englewood, NJ). The log incidence rate ratio
(IRR) was chosen because the follow‐up was dissimilar between the
two arms of the study. The log transformation makes this outcome
measure symmetric around 0 and yields a sampling distribution that
is closer to normality.
Heterogeneity was assessed by means of the statistical incon-
sistency Higgins I2 test.17 The latter examines the percentage of
interstudy variation, employing values ranging from 0% to 100%. A
value of I2 less than 40% indicates low severity heterogeneity,
between 40% and 75% moderate heterogeneity, and higher than
75% considerable heterogeneity.17,18 A random‐effects model was
employed to overcome the high degree of heterogeneity anticipated
among the available studies, which guarantees a more conservative
approach accounting for inter‐ and intrastudy variability. Publication
bias was evaluated using Egger’s test of the intercept. In addition, we
performed a meta‐regression analysis to investigate the impact of
specific PMI techniques on the MR recurrence rate and LVRR. P < .05
were considered statistically significant.
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3 | RESULTS
3.1 | Characteristics of the studies
All titles and abstracts retrieved by the literature search were assessed;
relevant or possibly relevant abstracts led to full paper screening. We
found 169 studies, 82 of which were excluded for being unrelated to the
topic of the present research. After a first screening, 44 full‐text articles
were further assessed for eligibility. In addition, three articles were
identified from the reference list of the original papers. From this
ultimate analysis, six articles were identified and thus included in our
systematic review and meta‐analysis.9-11,19-21 Figure 1 shows a
schematic representation of the selection process.
The studies retrieved were published between 2000 and 2019. Four
papers were prospective nonrandomized studies,9,11,19,21 one was a
randomized trial,10 and one was a retrospective observational study.20
The total number of patients of the selected studies was 559
(range 56‐138) with an overall mean age of 62.8 (61.4, 64.2) years. In
total, 284 patients (50.8%) underwent PMI in conjunction with MRA,
whereas 275 patients (49.2%) underwent isolated MRA. The mean
age for the PMI +MRA group and the MRA group was 62.9 (61.5,
64.3) and 62.8 (59.8, 65.8) years, respectively. All evaluated the
patients on the basis of the severity of heart failure, adopting the
New York Heart Association (NYHA) functional classification of heart
failure. All 6 articles showed an initial patient NYHA evaluation
corresponding to stages III and IV of the scale. General character-
istics of the patients are shown in Table 1.
In relation to the surgical technique employed, we identified two
different types of PM surgical interventions: papillary muscle
approximation (PMA) and papillary muscle relocation/papillary
muscle repositioning (PMRel/PMRep). All surgical interventions were
completed by coronary artery bypass graft.
3.2 | Quality of the studies
The average overall quality rating was 0.82 ± 0.81 with ratings
ranging from 0.25 to 2.08. Appendix A presents the average scores of
the items of the checklist. The analysis revealed lower scores related
to the external validity and for power analysis, which is related to the
quality of reporting. Acceptable interrater agreement was found
(κ = 0.81; %‐agree = 90.8).
3.3 | Follow‐up
A definite follow‐up period was described in all six of the studies
taken into the examination and completely attained in five
F IGURE 1 Preferred Reporting Items
for Systematic Review and Meta‐Analyses
flow diagram of the selection process
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studies.9,11,19-21 Thus, 413 (73.9%) patients reached the end of the
follow‐up period. However, a complete statistical analysis of the
mean follow‐up period could only be conducted on four stu-
dies.11,19-21 The mean follow‐up was 36.3 (20.4, 52.2) months.
Among the studies selected for this meta‐analysis, the longest follow‐
up period was 5 years.10 In the papers examined, the postoperative,
mid‐term and long‐term clinical status was determined according to
results obtained from echocardiographic imaging.
3.4 | MR recurrence
All studies reported the incidence of MR recurrence (Table 2). The ratio
of MR recurrence in the PMI +MRA group was 0.52 (0.32, 0.82).
Figure 2 shows a negative log IRR demonstrating that MR recurrence in
patients undergoing PMI +MRA was lower than in those who had
isolated MRA (log IRR, −0.66; lower‐upper limits: −.13, –0.20, p = .05;
I2 = 0.0%; p = .44; Egger’s test: intercept 0.35 (−0.78 to 1.51); p= .13; the
funnel plot is shown in the Figure S1). The results of the meta‐
regression are shown in the bubble plot in Figure 3. PMA, appeared to
have a significantly lower incidence of recurrent MR during the follow‐
up period compared with PMRel/PMRep techniques (p < .001).
3.5 | Left ventricular reverse remodeling
All six articles provide information about preoperative and post-
operative left ventricle (LV) diastolic dimensions to explore the
extent of LV remodeling (Table 2).
The forest plot in Figure 4 shows that the mean difference in
preoperative‐to‐postoperative LVEDD reduction between PMI +
MRA and the MRA group was −5.94% (lower, upper limits: −8.75%,
−3.13%; I2 = 64.33%; p = .015; Egger’s test: intercept 3.36 (−3.36,
10.07); p = .23; funnel plot in Figure S2). However, in both groups the
LVEDD reduction was lower than 10%: −8.72% in the PMI +MRA
group and −2.93% in the annuloplasty group.
The results of the meta‐regression are shown in the bubble
plot in Figure 5. Concerning the PMA technique, the meta‐
regression analysis revealed no evidence of the superiority of the
PMRel/PMRep approach over the PMA technique in terms of
LVRR (p = .33).
4 | DISCUSSION
Papillary muscles (PMs) displacement is the key pathophysiologic
factor of chronic ischemic mitral regurgitation (CIMR).22 There-
fore, additional procedures on PMs have been proposed in
addition to mitral ring annuloplasty (MRA), aimed at correcting
the outward displacement of PMs and finally reducing the
recurrence of mitral regurgitation (MR).8-11 However, the true
impact of these procedures on MR recurrence and left ventricular
reverse remodeling (LVRR) has not been completely elucidated.T
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Hence, the purpose of this study was to verify the efficacy of these
techniques compared with isolated MRA, and to test whether a
specific procedure was superior over the other in terms of
recurrence of MR and LVRR.
The major findings of our meta‐analysis were: (a) papillary muscle
interventions (PMIs) reduce the incidence of MR recurrence after MRA;
(b) PM relocation/repositioning (PMRel/PMRep) was more efficient than
papillary muscle approximation (PMA) in terms of MR recurrence; (c) the
decrease in left ventricle end‐diastolic diameter was slightly higher in the
PMI +MRA group than in the MRA group, yet it was <10%, which we
considered the cutoff for LVRR.16,23 (d) There was no difference in LVRR
between the PMRel/PMRep and PMA techniques.
In our study, we found a lower incidence of MR recurrence in the
PMI +MRA group than in the isolated MRA group. This finding is
consistent with the current literature, which reveals the superiority of
PMI associated with MRA over the isolated MRA procedure. These
TABLE 2 Outcomes
Author
Surgical
technique
MR
recurrence
rate (%) Grade 0 Grade 1+ Grade 2+ Grade 3+
Postoperative
LVEDD, mm
Postoperative
LVESD, mm
Percentage
reduction of
LVEDD (%)
Langer
et al21
PMRep +MRA 13.3 9 (30)a 17 (56.7)b 3 (10) 1 (3.3)c 54.8 ± 9.2 42.7 ± 7.8 −11.2
MRA alone 30 7 (23.3)d 14 (46.7)e 4 (13.3)f 5 (16.7)g 58.9 ± 7.5 48.3 ± 9.5 −2.48
Fattouch
et al19
PMRel +MRA 2.8 … … … … 51 ± 7 41 ± 6 −10.5
MRA alone 11.5 … … … … 55 ± 8 45 ± 5 −1.79
Wakasa
et al20
PMA +MRAb 30.8 … … … … 59 ± 7 … −10.6
MRA alone 33.3 … … … … 52 ± 9 … −7.14
Nappi
et al10
PMA +MRA 27 … … … … 56.5 ± 5.7 47.1 ± 5.9 −9.9
MRA alone 55.9 … … … … 60.6 ± 4.6 50.2 ± 4.4 −1.30
Pausch
et al11
PMRep +MRA 3.7 … … … … 58.6 ± 5.5 … −5.8
MRA alone 12.5 … … … … 55.5 ± 7.1 … −5.29
Harmel
et al9
PMRep +MRA 2 … … … … 57.3 ± 5.3 … −4.2
MRA alone 13.3 … … … … 58.8 ± 7.1 … 0.17
Note: The studies are shown in order of year of publication. Values are expressed as mean ± standard deviation and as number (%).
Abbreviations: LVEDD, left ventricle end‐diastolic diameter; LVESD, left ventricle end‐systolic diameter; MR, mitral regurgitation; MRA, mitral ring
annuloplasty; PMA, papillary muscle approximation; PMRel, papillary muscle relocation; PMRep, papillary muscle repositioning.
a25% of these patients had grade 0‐I of MR.
b32% of these patients had grade I‐II of MR.
cPatients had grade III‐IV of MR.
d11% of these patients had grade 0‐I of MR.
e11% of these patients had grade I‐II of MR.
f8% of these patients had grade II‐III of MR.
g8% of these patients had grade III‐IV of MR.
F IGURE 2 Forest plot of MR
recurrence in the PMI +MRA group and
isolated MRA group. MR, mitral
regurgitation; MRA, mitral ring
annuloplasty; PMI, papillary muscle
intervention
MICALI ET AL. | 5
favorable outcomes are attributable to restoration of the LV geome-
try10,24 and justify the indication of PMI associated to MRA, especially
when there are echocardiographic predictors of annuloplasty failure.25,26
The competence in a normal mitral valve is the result of the balance
of LV pressure force, which pushes leaflets toward the left atrium, and
tethering forces of the chordae that pull the leaflets, preventing leaflet
prolapse into the left atrium. In CIMR, the outward displacement of PM
results in augmented tethering force, overwhelming the LV pressure
force and thus resulting in leaflet malcoaptation. Hence, the reduction in
the closing force by apical displacement of the leaflets is now considered
as the main determinant of chronic ischemic regurgitation27,28 whereas
neither LV dilatation nor PM dysfunction have been shown to be able to
determine CIMR without PM displacement.29
Restrictive annuloplasty enhances mitral competence by reducing
the anteroposterior diameter of the mitral valve, which is greater in
the posterior portion of the mitral annulus than in the anterior. As a
result, the valve is transformed into a functionally unileaflet valve
with the valve orifice covered only by the anterior leaflet. In addition,
such an unbalanced reduction of the mitral annulus results in
tethering augmentation of the posterior leaflet that is progressively
worsened by continued left ventricular remodeling which is the main
cause of MR recurrence after annuloplasty.4,23,30
Therefore, additional procedures on PM help in eliminating this
augmented posterior leaflet tethering, thus resulting in a lower
incidence of recurrent MR compared with MRA alone. Nonetheless, it
has been shown that PMA is able to attenuate but not to eliminate
this tethering when associated with MRA,30 and this may explain the
poorer results found with this technique in terms of MR recurrence,
compared to PMRel/PMRep. In addition, PMA corrects valve
tethering by directing the deviated PM toward a central position31-33
and not towards the exact direction of PM dislocation secondary to
outward displacement. Indeed, the degree and direction of outward
displacement of PM can vary among patients with CIMR.34 In
addition, due to the heterogeneous geometric relationship between
PM the chordae and the leaflets, tethering force and direction can
differ within a single patient.
However, it has been observed that, in case of inferior myocardial
infarction, medial and lateral PM displacement is asymmetric with a
predominance for the medial PM, whereas in patients with CIMR
caused by anterior myocardial infarction the PM displacement is
symmetric.35,36 Nonetheless, to make things even more complicated,
it has been shown that asymmetric PM displacement may also result
in symmetric leaflet tenting.36 However, in the more common
asymmetric displacement, Hung et al,37 using an external patch
device to stabilize the PM‐LV wall complex in an animal model of
CIMR, showed that PM repositioning was effective in reducing
chronic regurgitation even in case of increased LV volumes.
Similarly, Liel‐Cohen et al38 addressed the outward displace-
ment of the medial PM by plicating the bulging wall, with the result
of reducing the leaflet tethering and MR. These findings are in
F IGURE 3 Bubble plot of the meta‐regression analysis of MR
recurrence rate in PMA and PMRel/PMRep. MR, mitral
regurgitation; PMA, papillary muscle approximation; PMRel,
papillary muscle relocation; PMRep, papillary muscle repositioning
F IGURE 4 Forest plot of reduction in end‐systolic diameter in the PMI +MRA group and isolated MRA group. MRA, mitral ring annuloplasty;
PMI, papillary muscle intervention
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contrast with results reported by Furukawa et al,39 who showed
comparable outcomes between PMA and PMRel. Such a difference
is ascribable to the small percentage of ischemic patients in their
cohort and the prevalence, in their study, of functional non‐
ischemic MR with its distinctive pathophysiological features, which
is different from those underlying CIMR. It is not surprising, in our
opinion, that the repositioning of the PMs to the mid‐line and their
alignment to the mitral annulus, is able to correct PM displacement
secondary to global remodeling. In contrast, PMA cannot be
effective in case of specific asymmetric tethering originating by
one PM or one of its heads. In these patients, PM repositioning is
more effective, but it should be guided by an accurate pathophy-
siology study to identify the PM mainly involved in the process with
its surrounding LV area, the specific ventricular geometric distor-
tion, as well as the exact direction of the tethering. In other words,
the repositioning/relocation of the PM involved should address the
specific distortion of the subvalvular apparatus but, at the same
time, should also correct the apical restriction of the posterior PM
secondary to MRA.
Finally, in our study, we found that in the PMI +MRA approach
the degree of LVRR was slightly higher than in the isolated MRA
approach. However, in both cases, we did not observe a reduction to
be considered LVRR. Our results are in accordance with LaPar et al40
who reported comparable results in terms of LVRR between the
subvalvular and the valvular approach.
Furthermore, the meta‐regression did not show any difference
between PMA and PMRel/PMRep.
However, while considering that the present findings must be
read with extreme caution because of the small number of studies
available, it is not surprising that the association of PMI and MRA
does not significantly influence LV remodeling, independently of the
PMI technique employed, because none of these procedures
addresses the remodeled ventricle, confirming the finding of Wakasa
et al20 that substantial LVRR can occur when PMI is performed in
conjunction with ventricular restoration techniques.
The lack of LVRR may lead to a vicious cycle for which recurrent
MR is more likely to occur as a result of the untreated LV remodeling.
This is true especially for critically ill patients (more enlarged and
spherical ventricles, severe tethering, etc), for whom a surgical
strategy addressing the annular dilatation and the concomitant
subvalvular dysfunction may not be sufficient. Thus, we believe that,
even though PMI per se can ameliorate MV geometry, rate of
recurrent MR, and ventricular remodeling, it is not able to efficiently
contrast long‐term continuous left ventricle remodeling.
4.1 | Limitations
This meta‐analysis has some important limitations that need to be
addressed. First of all, the number of patients included is insufficient to
draw a definitive conclusion and thus, to ultimately determine whether
the interventions are effective. The limited number of patients derives
from the paucity of studies since PMI is a relatively new technique.
Second, in the literature, there is a lack of substantial numbers of
prospective randomized studies comparing results from different
interventions. Third, relying on echocardiographic parameters predis-
poses to operator‐dependent results and values, which prevent an
absolute comparison between echocardiographic measurements. Fi-
nally, data on volume reduction was not unanimously available,
therefore we used LVEDD as an index of ventricular remodeling.
5 | CONCLUSION
Compared with isolated MRA, PMI combined with MRA can be
beneficial in re‐establishing the physiological MV anatomy and thus, in
reducing the rate of MR recurrence. In particular, PMRel/PMRep show
lower rates of recurrent MR than PMA. From our study, no substantial
advantage was found between PMI +MRA and MRA in terms of LVRR.
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APPENDIX A
Quality assessment
Item M SD
1 Study hypothesis/aim/objective described? 0.75 0.45
2 Main outcomes described in the introduction or
methods?
0.67 0.49
3 Participant characteristics described? 0.92 0.29
4 Contacted participants representative? 0.25 0.45
5 Prepared participants representative? 0.25 0.45
6 Participants recruited from the same population? 0.42 0.51
7 Participants recruited over the same time? 0.83 0.39
8 Measures and experimental tasks described? 0.83 0.39
9 Main outcome measures valid and reliable? 1.00 0.00
10 Task engagement assessed? 0.25 0.45
11 Confounders described and controlled for? 1.17 0.72
12 Statistical tests appropriate? 1.00 0.00
13 Main findings described? 1.00 0.00
14 Estimates of the random variability in data main
outcomes?
1.00 0.00
15 Probability values reported? 1.00 0.00
16 Withdrawals and drop‐outs reported? 0.67 0.49
17 Data dredging made clear? 0.58 0.51
18 Sufficient power analysis provided? 2.08 2.57
All items have a maximum score of 1.00 except for item 11 and
18, which have a maximum score of 2.00 and 5.00, respectively.
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